4//SEC Filing
Schoen Eric 4
Accession 0001437749-24-036546
CIK 0001069530other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:16 PM ET
Size
9.8 KB
Accession
0001437749-24-036546
Insider Transaction Report
Form 4
Schoen Eric
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-11-29−50,000→ 0 totalExercise: $1.18From: 2018-11-30Exp: 2028-10-31→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2024-11-29$1.18/sh+50,000$59,000→ 71,300 total - Sale
Common Stock
2024-11-29$3.82/sh−2,000$7,640→ 0 total(indirect: By limited liability corporation) - Sale
Common Stock
2024-11-29$3.86/sh−59,800$230,828→ 11,500 total
Footnotes (1)
- [F1]1. The sale reported in column 4 is a weighted average price. The shares were sold in multiple open market transactions at prices ranging from $3.81 to $3.89 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Documents
Issuer
CASSAVA SCIENCES INC
CIK 0001069530
Entity typeother
Related Parties
1- filerCIK 0001532303
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 4:16 PM ET
- Size
- 9.8 KB